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As part of an extensive study in the Portuguese
Island population of families with multiple pa-
tients suffering from bipolar disorder and schizo-
phrenia, we performed an initial genome-wide
scan of 16 extended families with bipolar disorder
that identified three regions on chromosomes 2,
11, and 19 with genome-wide suggestive linkage
and several other regions, including chromosome
6q, also approached suggestive levels of signifi-
cance. Dick et al. [2003: Am J Hum Genet 73:107–
114] recently reported in a study of 250 families
with bipolar disorder a maxLOD score of 3.61
near marker D6S1021 on chromosome 6q. This
study replicates this finding having detected a
peak NPL¼2.02 (P¼0.025) with the same marker
D6S1021(104.7 Mb). Higher-density mapping pro-
vided additional support for loci on chromosome
6 including marker D6S1021 with an NPL¼2.59
(P¼0.0068) and peaking at marker D6S1639
(125 Mb) with an NPL¼ 3.06 (P¼0.0019). A similar
pattern was detected with higher-density map-
ping of chromosome 11 with an NPL¼3.15
(P¼0.0014) at marker D11S1883 (63.1 Mb). Simula-
tions at the density of our fine mapping data
indicate that less than 1 scan out of 10 would find
two such scores genome-wide in the same scan by
chance. Our findings provide additional support
for a susceptibility locus for bipolar disorder on
6q, as well as, suggesting the importance of denser
scans. Published 2004 Wiley-Liss, Inc.{
INTRODUCTION
Bipolar disorder is characterized by periods of mania most
often alternating with periods of depression. More than half of
the bipolar patients in our studies also suffer psychotic
symptoms. Bipolar disorder affects approximately 1% of the
world population and has long been noted to demonstrate a
strong familial pattern [Tsuang and Faraone, 1990]. Over the
last 10 years, we have developed the Portuguese Island
Collection to study the genetics of bipolar disorder and
schizophrenia in a relatively homogeneous population [Pato
et al., 1997]. Geographically and genetically isolated popula-
tions have played a key role in disease gene identification
[Peltonen, 2000]. Focused on theAzoreanandMadeira Islands,
this study has benefited from the unique parallel history of
these two archipelagoes (reviewed in Sklar et al. [2004]).
Despite their relative isolation, the islands are served by
modern centralized health systems, and we have established
close collaborations with all of the clinicians serving this
population.Wehave recently reported linkages to chromosome
5q and 8p in schizophrenia in this population [Sklar et al.,
2004]. The strongest linkage was found on chromosome 5q.
This region has recently received strong support from a meta-
analysis of 20 genome-wide scans [Lewis et al., 2003].
Our initial studies of bipolar disorder in this population
detected several families segregating an expansion mutation
at the SCA8 locus on chromosome 13q21 [Pato et al., 2000]. In
order to identify additional risk loci, a genome-wide scan of
bipolar disorder was performed on families from the Azores,
Madeira, and the city of Coimbra on the Portuguesemainland.
MATERIALS AND METHODS
Subjects
Families with two or more affected individuals were as-
certained from systematic screening of all treating clinicians,
treatment facilities, social services, and extensive family
interviews. In the Azores, all four psychiatric hospitals and
the two general hospitals participated in the study. Similarly
inMadeira, both psychiatric hospitals and the general hospital
participated. On the mainland, families were identified by our
collaborators at the University of Coimbra. Informed consent
was obtained in writing from all subjects for participation in
the genetic and family studies. Collection of blood and family
history information was approved by all of the appropriate
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Institutional Review Boards. For our population isolate
studies, families were ascertained if both of the proband’s
parents and all four of the grandparents were native to the
islands. Diagnoses were made from data obtained with the
Diagnostic Interview for Genetic Studies (DIGS) [Nurnberger
et al., 1994]. Interviews were performed at the site of the
subjects clinical care, in their homes, or at an alternate site of
the subject’s choosing. Interviewers were highly trained psy-
chiatrists, psychologists, or social workers. Inter-rater relia-
bility was assured by careful training and evaluation of each
interviewer prior to study onset and annually throughout.
Periodically, reliability was assessed by having a set of
12 subjects assessed independently by interviewers from
different study sites and by a senior supervisor. The chance
corrected inter-rater agreement, k, was high for the diagnoses
of schizophrenia, bipolar disorder, and schizoaffective disorder
(k¼ 0.9–0.94). Items related to the diagnosis of schizotypy
showed slightly less agreement (k 0.75). Thorough clinical
narratives were completed for all subjects. Best estimate
diagnoses according toDSM-IVweremade by two independent
blinded researchers after review of clinical information, DIGS,
Operational Criteria Checklist for Psychotic Illness (OPCRIT)
[McGuffin et al., 1991] and written narratives. All cases where
there was disagreement were reviewed by a third senior
psychiatrist blind to the status of the case (MT Pato, MD).
Genotyping
Genomic DNA was extracted from whole blood according to
standard protocols. A genome-wide screen was performed
using amodified set of theCooperativeHumanLinkageCentre
ScreeningSet, version6.0.Fluorescently labeledmarkerswere
detected on an ABI-3700 and allele sizes were called using
Genotyper v. 3.6 software. The marker map positions were
based on the Marshfield map. PEDMANAGER software was
used for allele binning and inheritance analysis. For fine
mapping on chromosomes 6 and 11, we genotyped an
additional 14–16 microsatellite markers in each region with
an average inter-marker distance of 4.2 cM.
Data Analysis
Non-parametricmulti-point linkage analysis of the datawas
performed using GENEHUNTER 2.0 [Markianos et al., 2001].
To establish threshold for suggestive and significant genome-
wide linkage, simulation were performed. These simulations
were performed using GENSIM (MJD, unpublished), a
pedigree genotype simulator that attaches to GENEHUNTER
[Rioux et al., 2000; Hirschhorn et al., 2001; Laitinen et al.,
2001] that matched our dataset in relevant variables.
RESULTS
Families were chosen for genotyping based on the presence
of at least an affected relative pair appropriate for linkage
analysis.All families thathadbeen completely evaluatedat the
time of this study were included for genotyping. This initial
genome scan of bipolar disorder includes 16 families with an
average of 2.9 affected: 10 families were from the Azorean
Islands, 2 from Madeira, and 4 from Coimbra on the
Portuguese mainland (Table I).
A single narrow phenotypic model was chosen that included
only bipolar disorder-type 1 and schizoaffective disorder-
bipolar type. Genotyping data were available for analysis for
102 family members of which 47 members were affected with
either bipolar disorder (n¼ 46) or schizoaffective disorder-
bipolar (n¼ 1) for 366 microsatellite markers with an average
inter-marker spacing of 9.6 cM.
Non-parametricmulti-point linkage analysis of the datawas
performed using GENEHUNTER 2.0 [Markianos et al., 2001].
Nominally significant P-values were obtained in seven regions
(see Fig. 1 and Table II). The maximum NPL was located at
D11S987 (NPL¼ 2.58, P¼ 0.007). Recent evidence suggests
that thresholds established assuming full pedigree and
genotyping information are overly conservative under the
experimental conditions encountered in a typical primary
10 cMgenome scanwith respect tomarker density, percentage
of missing genotypes, and availability of parental information
[Wiltshire et al., 2002]. In order to estimate the strength of the
observations of linkage in our initial 10 cM genome scan, we
performed genome-wide simulations under the model that no
genes were present that affected disease risk. We designed
simulations that matched our real data in all relevant
variables: family structure, individuals available for genotyp-
ing, percentage of genotypes achieved in those individuals
available for genotyping, marker spacing, and marker hetero-
zygosity. These simulations were performed using GENSIM
(MJD, unpublished), a pedigree genotype simulator that
attaches to GENEHUNTER [Rioux et al., 2000; Hirschhorn
et al., 2001; Laitinen et al., 2001]. One hundred complete
genome scans were simulated and these show that the
threshold for suggestive linkage (i.e., the level of linkage
expected once per genome scan by chance) is an NPL¼ 2.2 and
the threshold for declaring significant linkage (i.e., linkage
expected once per 20 genome scans by chance for a genome-
wide P¼ 0.05) is NPL¼ 3.0.
We initiated follow up studies of our original bipolar linkage
signals focusing on chromosomes 6 and 11 because these two
regions also showed linkage signals in this population with
the phenotype of psychosis. We genotyped an additional 14–
16microsatellitemarkers in each regionwith anaverage inter-
marker distance of 4.2 cM. The higher-density mapping
provided additional support for loci on chromosome 11 with
a maximum NPL¼ 3.15 (P¼ 0.0014) at marker D11S1883
(63.1 Mb) (Fig. 2). A similar pattern was detected with higher-
densitymapping of chromosomes 6 includingmarkerD6S1021
with an NPL¼ 2.59 (P¼ 0.0068) and with a maximum
NPL¼ 3.06 (P¼ 0.0019) at marker D6S1639 (125 Mb).
Simulations were performed as described above incorporat-
ing the increased density of markers studied in chromosomes
6 and 11 and indicated an NPL of 3.6 represents genome-wide
significance, and anNPL of 2.8 would be suggestive of linkage.
Simulations at the density of our fine mapping data indicate
that less than 1 scan out of 10 would find two such scores
genome-wide in the same scan by chance.
DISCUSSION
No consistently replicated linkage has been found for bipolar
disorder.Arecentlycompletedmeta-analysisbySeguradoetal.
[2003] failed to identify significant linkage in a combined data
set from 18 genome scans for bipolar disorder. An up to date
review of both positive and negative findings and the limita-
tions of meta-analytic methods are also summarized in this
same report [Segurado et al., 2003]. More recently, Dick et al.
[2003] reported, ina studyof 250 familieswithbipolardisorder,
a maximum LOD score of 3.61 (genome-wide P< 0.05) at 114
TABLE I. Families Segregating for Bipolar Disorder
No. affected/family Families Affected
2 6 12
3 6 18
4 3 12
5 1 5
Totals 16 47
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cM near marker D6S1021 on chromosome 6q. Subsequent
corrections for 12 identical twins lowered the LOD score to
below genome wide significance. However, the analysis of the
combined waves 1–3 of the NIMH collaborative yielded a
maxLOD score of 3.8, which again achieves genome wide
significance (personal communication, John Nurnberger). A
study by Ewald et al. [2002], also identified a linkage signal on
6q with a maximum LOD of 2.59 (P¼ 0.00035) at marker
D6S1021. Our study supports these findings having detected
an NPL¼ 2.02 (P¼ 0.025) with the same marker D6S1021
(104.73 Mb), in our low-resolution genome-wide scan. Though
achieving nominal significance, this region would not have
been considered as achieving even suggestive level of sig-
nificance genome-wide. However, our fine mapping of this
region provided additional support for a number of loci on
chromosomes 6 includingmarkerD6S1021with anNPL¼ 2.59
(P¼ 0.0068) and a maximum NPL of 3.06 (P¼ 0.0019) at
marker D6S1639 (125 Mb). This highlights one of the
limitations of meta-analysis using genome scans at 10 cM
spacing. The failure to achieve significance onaparticular scan
might be due to incomplete linkage information at that
resolution. This underscores the importance of additional
genome scans of bipolar disorder with more complete linkage
information derived from higher resolution scans.
Our10 cMgenome-wide scanalso revealed two other areas of
suggestive linkage. The second highest NPL¼ 2.37 (P¼ 0.01)
was obtained on chromosome 19 atmarkerD19S714 (15.5Mb),
and the third region on chromosome 2 had a maximum
NPL¼ 2.28 (P¼ 0.014) atmarkerD2S1356 (43.35Mb) between
markers D2S2374 (35.6 Mb) and D2S1394 (73 Mb). Interest-
ingly, the Dick et al. [2003] study also revealed suggestive
linkage near maker D2S1394 with a maximum LOD score of
2.62 (P< 0.1 genome-wide).
Fig. 1. Non-parametric multi-point linkage analysis by GENEHUNTER 2.0 in bipolar disorder. For each chromosome, the total genetic length is shown
below the x-axis. Tick marks indicate the position of the microsatellite markers. The multipoint NPL scores (y-axis) for bipolar disorder.
TABLE II. Regions With Peak NPLs Scores With Nominal
Significance Obtained With a 10 cM Density Whole Genome Scan
Chromosome Marker Position (Mb) NPL P-value
2 D2S1356 43.35 2.28 0.014
5 D5S2501 110.2 2.11 0.021
6 D6S1021 104.73 2.02 0.026
7 D7S3051 18.03 1.83 0.038
11 D11S987 67.6 2.58 0.007
19 D19S714 15.5 2.37 0.012
20 D20S478 37.9 2.18 0.018
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Given the modest number of pedigrees analyzed in this
initial study (M¼ 16), the strength of the linkage signal
is consistent with a degree of disease homogeneity within this
geographically isolated population. The ability to more easily
identify areas of linkage in population isolates has been a
major foundation of this type of study. The evidence from the
Portuguese islands, as well as, studies in other population
isolates supports this notion. However, the fact that both our
bipolar and our schizophrenia studies have identified linkage
in areas identified by other groups supports the general-
izability of the population isolate based findings.
In summary, we report strong suggestive evidence for
linkage in bipolar disorder to chromosomes 6 and 11 in a
population-based sample of Portuguese Island families. The
strength of findings from several independent reports on
chromosome 6q16.3-21 makes it a solid susceptibility locus
for bipolar disorder and suggests that positional cloning
approaches are warranted. In addition, our own genome scan
using psychosis as a heritable symptom shared between
bipolar disorder and schizophrenia not only identifies a
potential linkage to the region of chromosome 5 seen in our
schizophrenia scan, but also supports the same pattern for the
chromosome 6 and 11 regions reported here as potentially
linked to bipolar disorder [Sklar et al., 2004]. These results
further support the possibility that there may be shared genes
for vulnerability to psychosis in bipolar disorder and schizo-
phrenia.
ELECTRONIC-DATABASE INFORMATION
URLs for data presented herein are as follows: Marshfield
Center for Medical Genetics, http://research.marshfieldclinic.
org/genetics/
UCSC Genome Bioinformatics, Human Genome Browser,
http://genome.ucsc.edu/
http:/ /www-genome.wi.mit.edu/personal/mjdaly/daly-
software-page.html.
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Lifetime Achievement Award 2003
At its annualWCPGmeeting, the ISPG awards the Lifetime
Achievement Award to a Scientist or Scientists who made
major contributions to the advancement of the field of
Psychiatric Genetics. The Lifetime Achievement Award con-
sists of the golden DNA helix specially designed by the
internationally recognized sculptor Charles Reina from Long
Island, NY. The copyright for the sculpture is owned by ISPG.
Previous awardeeswere SeymourKety andGeorgeWinokur
(1993), Ming Tsuang (1995), Irving I. Gotteman (1997), Ted
Reich (1999), Michael Conneally (2001), and Jules Angst and
Nikki Erlemeyer-Kimling (2002).
This year the ISPG award committee, chaired by Peter
McGuffin (London, UK), has selected, in consultation with
the ISPG Board, C. Robert Cloninger (St. Louis, USA) as the
2003 ISPG Lifetime Achievement Awardee. The Award
Ceremony took place during the WCPG Banquet on Tuesday,
October 7, 2003. Dr. Cloninger also delivered the Awardee
Lecture during the WCPG Plenary session on Wednesday,
October 8 to all attending WCPG members and participants.
Dr. C. Robert Cloninger has been a faculty member of
WashingtonUniversity in St. Louis,Missouri since 1973. He is
the Wallace Renard Professor of Psychiatry, Genetics and
Psychology, and he is the Director of The Center for Psy-
chobiology of Personality. His major research interests have
focused on alcoholism, schizophrenia, personality disorders,
and somatoform disorders.
In 1966, Dr. Cloninger graduated with a Bachelor of Arts in
Philosophy, Anthropology and Psychology from theUniversity
of Texas in Austin. He received his medical degree in 1970 at
Washington University in St. Louis, and then received his
postdoctoral training in Genetics at the University of Hawaii
with Newton Morton in 1978.
His publications have included over 300 articles and 5 books
on genetics, psychobiology, and classification of alcoholism,
personality disorders, and psychopathology. He has been an
editor or associate editor on numerous journals, including
Behavior Genetics and The American Journal of Human
Genetics, and he has been on the editorial boards for other
journals such as Neuropsychiatric Genetics.
Some of Dr. Cloninger’s past awards include an Honorary
Doctorate from the University of Umea, Sweden, The Lifetime
Achievement Award from the American Academy of Addiction
Medicine in 2000, The Strecker Award from the Institute of
Pennsylvania Hospital, The Isaacson Memorial Award,
ISBRA, and the Adolf Meyer Award, APA, as well as several
distinguished visiting professorships.
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